Beneficial effects of L-arginine on reducing obesity: potential mechanisms and important implications for human health.

Department of Animal Science, Faculty of Nutrition, Texas A&M University, College Station, TX 77843, USA.
Amino Acids (Impact Factor: 3.65). 05/2010; 39(2):349-57. DOI: 10.1007/s00726-010-0598-z
Source: PubMed

ABSTRACT Over the past 20 years, growing interest in the biochemistry, nutrition, and pharmacology of L-arginine has led to extensive studies to explore its nutritional and therapeutic roles in treating and preventing human metabolic disorders. Emerging evidence shows that dietary L-arginine supplementation reduces adiposity in genetically obese rats, diet-induced obese rats, finishing pigs, and obese human subjects with Type-2 diabetes mellitus. The mechanisms responsible for the beneficial effects of L-arginine are likely complex, but ultimately involve altering the balance of energy intake and expenditure in favor of fat loss or reduced growth of white adipose tissue. Recent studies indicate that L-arginine supplementation stimulates mitochondrial biogenesis and brown adipose tissue development possibly through the enhanced synthesis of cell-signaling molecules (e.g., nitric oxide, carbon monoxide, polyamines, cGMP, and cAMP) as well as the increased expression of genes that promote whole-body oxidation of energy substrates (e.g., glucose and fatty acids) Thus, L-arginine holds great promise as a safe and cost-effective nutrient to reduce adiposity, increase muscle mass, and improve the metabolic profile in animals and humans.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Numerous studies have demonstrated the impact of functional fibers on gut microbiota and metabolic health but some less well-studied fibers and/or fractions of foods known to be high in fiber still warrant examination. The aim of this study was to assess the effect of yellow pea-derived fractions varying in fiber and protein content on metabolic parameters and gut microbiota in diet induced obese (DIO) rats. We hypothesized that the yellow pea fiber fraction would improve glycemia and alter gut microbiota. Rats were randomized to 1 of 5 isocaloric dietary treatments for 6 weeks: (1) control; (2) oligofructose (OFS); (3) yellow pea fiber (PF); (4) yellow pea flour (PFL); or (5) yellow pea starch (PS). Glycemia, plasma gut hormones, body composition, hepatic triglyceride content, gut microbiota and mRNA expression of genes related to hepatic fat metabolism were examined. PFL attenuated weight gain compared to control, PF, and PS (P < 0.05). PFL, PS and OFS had significantly lower final percent body fat compared to control. OFS but not the pea fraction diets reduced food intake compared to control (P < 0.05). PF resulted in lower fasting glucose and glucose area under the curve compared to control. Changes in gut microbiota were fraction-specific and included a decrease in Firmicutes (%) for OFS, PF, and PFL compared to control (P < 0.05). The Firmicutes/Bacteroidetes ratio was reduced with OFS, PF, and PFL when compared to PS (P < 0.05). Taken together, this work suggests that yellow pea-derived fractions are able to distinctly modulate metabolic parameters and gut microbiota in obese rats.
    Nutrition Research 08/2014; 34(8). DOI:10.1016/j.nutres.2014.07.016 · 2.59 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Amino acids (AA) have enormous physiological importance, serving as building blocks for proteins and substrates for synthesis of low-molecular-weight substances. Based on growth or nitrogen balance, AA were traditionally classified as nutritionally essential or nonessential for animals. Although those AA that are not synthesized in eukaryotes (nutritionally essential AA, EAA) must be present in animal diets, nutritionally nonessential AA (NEAA) have long been ignored for all species. Emerging evidence shows that nonruminants cannot adequately synthesize NEAA or conditionally essential AA (CEAA) to realize their growth or anti-infection potential. Likewise, all preformed AA are needed for high-producing cows and rapidly growing ruminants. Many NEAA and CEAA (e.g., arginine, glutamine, glutamate, glycine, and proline) and certain EAA (e.g., leucine and tryptophan) participate in cell signaling, gene expression, and metabolic regulation. Thus, functions of AA beyond protein synthesis must be considered in dietary formulations to improve efficiency of nutrient use, growth, development, reproduction, lactation, and well-being in animals.
    02/2014; 2:387-417. DOI:10.1146/annurev-animal-022513-114113
  • [Show abstract] [Hide abstract]
    ABSTRACT: Forty-eight Duroc x Landrace x Large White gilts were used to determine the relationship between proteome changes of longissimus muscle and intramuscular fat (IMF) content in arginine-supplemented pigs. Beginning at 60 kg BW, pigs were fed a corn- and soybean meal-based diet supplemented or not with 1% L-arginine until they reached a BW of 100 kg. Supplementation with 1% L-arginine did not affect the growth performance or carcass traits, while it increased IMF content by 32% (P < 0.01), it also decreased the drip loss at 48 h post-mortem and the b* meat color value at 24 h post-mortem; supplementation with 1% dietary L-arginine did not change the proportion of SFA and MUFA in muscle lipids. The proteome changes in longissimus muscle between the control and supplemented pigs showed that L-arginine significantly influenced the abundance of proteins related to energy metabolism, fiber type and structure. The increase in IMF content was positively correlated with the increased abundance of slow twitch troponin I (TNNI1) protein and negatively correlated with myosin heavy chain IIb (MyHC IIb) protein content. It is suggested that the proteome changes in longissimus muscle contributed to the greater IMF content in L-arginine supplemented pigs.
    PLoS ONE 10(1):e0117294. DOI:10.1371/journal.pone.0117294 · 3.53 Impact Factor